The Federal Register

Public Health Assessments Completed

Mon, Nov 28 2005 11:00:00 GMT

This notice announces those sites for which ATSDR has completed public health assessments during the period from July through September 2005. This list includes sites that are on or proposed for inclusion on the National Priorities List (NPL) and includes sites for which assessments were prepared in response to requests from the public.

Advisory Committee on Childhood Lead Poisoning Prevention: Notice of Charter Renewal

Mon, Nov 28 2005 11:00:00 GMT

This gives notice under the Federal Advisory Committee Act (Pub. L. 92463) of October 6, 1972, that the Advisory Committee on Childhood Lead Poisoning Prevention, Centers for Disease Control and Prevention of the Department of Health and Human Services, has been renewed for a 2year period extending through October 31, 2007.

For further information, contact Mary Jean Brown, R.N., Sc.D., Executive Secretary, Advisory Committee on Childhood Lead Poisoning Prevention, Centers for Disease Control and Prevention of the Department of Health and Human Services, 4470 Buford Highway, M/S F40 Atlanta, Georgia 30441.

The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee
[[Page 71311]]
management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Diseases Registry.

Dated: November 17, 2005.
Alvin Hall,
Director, M

Board of Scientific Counselors, National Center for Infectious Diseases: Notice of Charter Renewal

Mon, Nov 28 2005 11:00:00 GMT

This gives notice under the Federal Advisory Committee Act (Pub. L. 92463) of October 6, 1972, that the Board of Scientific Counselors, National Center for Infectious Diseases, Centers for Disease Control and Prevention of the Department of Health and Human Services, has been renewed for a 2year period extending through October 31, 2007.

For further information, contact Rima Khabbaz, Executive Secretary, Board of Scientific Counselors, National Center for Infectious Diseases, Centers for Disease Control and Prevention of the Department of Health and Human Services, 1600 Clifton Road, M/S C2, Atlanta, Georgia 30303.

The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register Notices pertaining to announcements of meetings and other Committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.

Dated: November 17, 2005.
Alvin Hall,
Director, Manage

Submission for OMB Review; Comment Request

Mon, Nov 28 2005 11:00:00 GMT

Title: Methodology for Determining If an Increase in a State's Child Poverty Rate Is the Result of TANF.

OMB No.: 09700186.

Description: In accordance with Section 413(i) of the Social Security Act and 45 CFR part 284, the Department of Health and Human Services (HHS) intends to reinstate the following information collection requirements. For instances when Census Bureau data show that a State's child poverty rate increased by 5 percent or more from one year to the next, a State may submit independent estimates of its child poverty rate. If HHS determines that the State's independent estimates are not more reliable than the Census Bureau estimates, HHS will require the State to submit an assessment of the impact of the TANF program(s) in the State on the child poverty rate. If HHS determines from the assessment and other information that the child poverty rate in the State increased as a result of the TANF program(s) in the State, HHS will then require the State to submit a correctiv

President's Committee for People With Intellectual Disabilities: Notice of Meeting

Mon, Nov 28 2005 11:00:00 GMT

Pursuant to Section 10(a) of the Federal Advisory Committee Act as amended (5 U.S.C. Appendix 2) notice is hereby given that the President's Committee for People with Intellectual Disabilities will hold its third quarterly meeting by telephone conference call to discuss items related to people with intellectual disabilities. The conference call will be open to the public to listen, with callins limited to the number of telephone lines available. Individuals who plan to call in and need special assistance, such as TTY, assistive listening devices, or materials in alternative format, should inform Ericka Alston, Executive Assistant, President's Committee for People with Intellectual Disabilities, Telephone2026190634, Fax202205 9519, Email: ealston@acf.hhs.gov, no later than November 30, 2005. Efforts will be made to meet special requests received after that date, but availability of special needs accommodations to respond to these requests cannot be guarant

Agency Information Collection Activities: Proposed Collection; Comment Request

Mon, Nov 28 2005 11:00:00 GMT

Agency Information Collection Activities: Proposed Collection; Comment Request

Mon, Nov 28 2005 11:00:00 GMT

Agency Information Collection Activities: Proposed Collection; Comment Request

Mon, Nov 28 2005 11:00:00 GMT

Agency Information Collection Activities: Proposed Collection; Comment Request

Mon, Nov 28 2005 11:00:00 GMT

60-Day Notice; Agency Information Collection Activities: Proposed Collection; Comment Request

Mon, Nov 28 2005 11:00:00 GMT

Grants.gov Program Management Office Agency Information Collection Activities: Proposed Collection; Comment Request

Mon, Nov 28 2005 11:00:00 GMT

Grants.gov Program Management Office; Agency Information Collection Activities: Proposed Collection; Comment Request

Mon, Nov 28 2005 11:00:00 GMT

Agency Information Collection Activities: Proposed Collection; Comment Request

Mon, Nov 28 2005 11:00:00 GMT

Agency Information Collection Activities: Proposed Collection; Comment Request

Mon, Nov 28 2005 11:00:00 GMT

Draft OIG Compliance Program Guidance for Recipients of PHS Research Awards

Mon, Nov 28 2005 11:00:00 GMT

This Federal Register notice seeks the comments of interested parties on draft compliance guidance developed by the Office of Inspector General (OIG) for recipients of extramural research awards from the National Institutes of Health (NIH) and other agencies of the U.S. Public Health Service (PHS). Through this notice, OIG is setting forth its general views on the value and fundamental principles of compliance programs for colleges and universities and other recipients of PHS awards for biomedical and behavioral research and the specific elements that these award recipients should consider when developing and implementing an effective compliance program.

National Cancer Institute; Notice of Closed Meeting

Mon, Nov 28 2005 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Cancer Institute Special Emphasis Panel, Cancer Etiology.

Date: December 16, 2005.

Time: 8 a.m. to 5 p.m.

Agenda: To review and evaluate grant applications.

Place: Marriott Bethesda North Hotel & Conference Center, 5701 Marinelli Road, Bethesda, MD 20852.

Contact Person: Michael B. Small, PhD, Scientific Review Administrator, Resear

National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Closed Meeting

Mon, Nov 28 2005 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C, as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Arthritis and Musculoskeletal and Skin Diseases Special Emphasis Panel, Program Project Applications.

Date: November 22, 2005.

Time: 8 a.m. to 4 p.m.

Agenda: To review and evaluate grant applications.

Place: Double Tree Rockville, 1750 Rockville Pike, Rockville, MD 20852.

Contact Person: Eric H. Brown, PhD, Scientific Re

National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Closed Meeting

Mon, Nov 28 2005 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

Name of Committee: National Institute of Arthritis and Musculoskeletal and Skin Diseases Special Emphasis Panel, Small Research Grants (R03).

Date: December 5, 2005.

Time: 8:30 a.m. to 5 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, NIAMS, One Democracy, 6701 Democracy Boulevard 824, Bethesda, MD 20892, (Telephone Co

National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Closed Meeting

Mon, Nov 28 2005 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

Name of Committee: National Institute of Arthritis and Musculoskeletal and Skin Diseases Special Emphasis Panel, Core Center Grants (P30).

Date: December 1213, 2005.

Time: 8 a.m. to 3 p.m.

Agenda: To review and evaluate grant applications.

Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814.

Contact Person: Yan Z

National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Closed Meeting

Mon, Nov 28 2005 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

Name of Committee: National Institute of Arthritis and Musculoskeletal and Skin Diseases Special Emphasis Panel, Center Core Grants (P30).

Date: December 8, 2005.

Time: 8:30 a.m. to 5 p.m.

Agenda: To review and evaluate grant applications.

Place: Double Tree Rockville, 1750 Rockville Pike, Rockville, MD 20852.

Contact Person: Helen Lin, PhD, Scientific Review

National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting

Mon, Nov 28 2005 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

Name of Committee: National Institute of Biomedical Imaging and Bioengineering Special Emphasis Panel, P01 Grant Review. December 5, 2005.

Time: 1 p.m. to 5 p.m.

Agenda: To review and evaluate grant applications.

Place: II Democracy Plaza, 6707 Democracy Blvd., 223, Bethesda, MD 20817 (Telephone Conference Call).

Contact Person: Prabha L. Atreya, PhD., Scientific

National Institute of Child Health and Human Development; Notice of Closed Meeting

Mon, Nov 28 2005 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which could constitute a clearly unwarranted invasion of personal privacy. [[Page 71322]]

Name of Committee: National Institute of Child Health and Human Development Special Emphasis Panel, Insulin Resistance in PCOS Sequelae and Treatment.

Date: November 30, 2005.

Time: 2 p.m to 4 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, 6100 Executive Boulevard, Room 5B01, Rockville, MD 20852, (Teleph

National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting

Mon, Nov 28 2005 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which could constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel, Podiatry Summer Research Fellowships.

Date: December 13, 2005.

Time: 2 p.m to 3 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892, (Telephone Confer

National Institute of General Medical Sciences; Notice of Closed Meeting

Mon, Nov 28 2005 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

Name of Committee: National Institute of General Medical Sciences Special Emphasis Panel, MBRS Support of Continuous Research Excellence.

Date: December 7, 2005.

Time: 1 p.m. to 4 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, Natcher Building, 45 Center Drive, Room 3AN12, Bethesda, MD 20892 (Telephone Conference Cal

National Institute of General Medical Sciences; Notice of Closed Meeting

Mon, Nov 28 2005 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of General Medical Sciences Special Emphasis Panel, R13 Conference Grants.

Date: December 12, 2005.

Time: 9 a.m. to 5 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institute of General Medical Sciences, Natcher Bldg, 45 Center Drive, 3AN12, Bethesda, MD 20892 (Virtual Meeting).

Contact Person: Arthu

National Institute of General Medical Sciences; Notice of Closed Meeting

Mon, Nov 28 2005 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

Name of Committee: National Institute of General Medical Sciences Special Emphasis Panel, E. coli Model Organism Resource.

Date: December 13, 2005.

Time: 10:30 a.m. to 3:30 p.m.

Agenda: To review and evaluate grant applications.

Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 20814.

Contact Person: Brian Pike, PhD., Office of Scientific Review, Na

National Institute of Neurological Disorders and Stroke; Notice of Closed Meetings

Mon, Nov 28 2005 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Neurological Disorders and Stroke Special Emphasis Panel, Training and Career Development.

Date: November 22, 2005.

Time: 2 p.m. to 5 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852 (Telephone Conference Call).

National Institute of Neurological Disorders and Stroke; Notice of Closed Meetings

Mon, Nov 28 2005 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

Name of Committee: National Institute of Neurological Disorders and Stroke Special Emphasis Panel, Narcolepsy Investigations.

Date: December 12, 2005.

Time: 3 p.m. to 5 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, Rockville, MD (Telephone Conference Call).

Contact Person: Andrea Sawczuk, DDS, PhD, Scientific Re

National Institute on Drug Abuse; Notice of Closed Meeting

Mon, Nov 28 2005 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute on Drug Abuse Special Emphasis Panel, Program Projects.

Date: December 7, 2005.

Time: 10 a.m. to 12 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, 6101 Executive Boulevard, Rockville, MD 20852 (Telephone Conference Call).

Contact Person: Gerald L. McLaughlin, PhD, Scientific Rev

Office of Biotechnology Activities, Office of Science Policy, Office of the Director; Amended Notice of Meeting

Mon, Nov 28 2005 11:00:00 GMT

Notice is hereby given of a change in the meeting of the National Science Advisory Board for Biosecurity (NSABB), November 21, 2005, 9 a.m. to 6 p.m., National Institutes of Health, Building 31, Conference Room 10, CWing, Bethesda, MD 20892 which was published in the Federal Register on November 1, 2005, 70 FRN6590865909.

The meeting has been changed to include a closed session immediately following the open session of the NSABB meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended.

Dated: November 16, 2005.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 0523348 Filed 112505; 8:45 am]
BILLING CODE 414001M

Center for Scientific Review; Notice of Closed Meetings

Mon, Nov 28 2005 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C, as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: Center for Scientific Review Special Emphasis Panel; Immunology of Regulatory T Cells.

Date: November 30, 2005.

Time: 2:30 p.m. to 3:30 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. (Telephone Conference Call).

Contact Person: Cathleen L. Cooper, PhD, S

Center for Scientific Review; Amended Notice of Meeting

Mon, Nov 28 2005 11:00:00 GMT

Notice is hereby given of a change in the meeting of the Center for Scientific Review Special Emphasis Panel, November 21, 2005, 10 a.m. to November 21, 2005, 11 a.m., National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 which was published in the Federal Register on November 2, 2005, 70 FR 6644966451.

The meeting will be held November 28, 2005, from 3 p.m. to 4 p.m. The meeting location remains the same.

The meeting is closed to the public.
[[Page 71326]]

Dated: November 18, 2005.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 0523342 Filed 112505; 8:45 am]
BILLING CODE 414001M

Center for Scientific Review; Notice of Closed Meeting

Mon, Nov 28 2005 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

Name of Committee: Center for Scientific Review Special Emphasis Panel; Kidney, Nutrition, Obesity and Diabetes (KNOD) Member Conflicts.

Date: November 28, 2005.

Time: 11 a.m. to 12:30 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call).

Contact Pe

Agency Information Collection Activities: Submission for OMB Review; Comment Request

Mon, Nov 28 2005 11:00:00 GMT

Periodically, the Substance Abuse and Mental Health Services Administration (SAMHSA) will publish a summary of information collection requests under OMB review, in compliance with the Paperwork Reduction Act (44 U.S.C. Chapter 35). To request a copy of these documents, call the SAMHSA Reports Clearance Officer on (240) 2761243. Project: Call Monitoring of National Suicide Prevention Lifeline Form NEW

The Substance Abuse and Mental Health Services Administration's (SAMHSA), Center for Mental Health Services has funded a National Suicide Prevention Lifeline Network, consisting of a single tollfree telephone number that routes calls from anywhere in the United States to a network of local crisis centers. In turn, the local centers link callers to local emergency, mental health, and social service resources.

To ensure quality, the vast majority of crisis centers conduct on site monitoring of selected calls by supervisors or trainers using unobtrusive listening devices. To monitor the quali

Agency Information Collection Activities: Submission for OMB Review; Comment Request

Mon, Nov 28 2005 11:00:00 GMT

Periodically, the Substance Abuse and Mental Health Services Administration (SAMHSA) will publish a summary of information collection requests under OMB review, in compliance with the Paperwork Reduction Act (44 U.S.C. Chapter 35). To request a copy of these documents, call the SAMHSA Reports Clearance Officer on (240) 2761243. Project: The Evaluation of Networking Suicide Prevention Hotlines FollowUp AssessmentNEW

With input from multiple experts in the field of suicide prevention, the project created a telephone interview survey to collect data on followup assessments of consen